AI-powered Drug Discovery Startups

Lavo Life Sciences offers computational molecular simulations to pharmaceutical companies, helping them optimize drug formulations, reduce experimental costs, and accelerate the path to clinical trials and regulatory approval.

3 investors

Nanograb develops gene therapy delivery systems using artificial intelligence to identify peptide-nanoparticle combinations that transport genetic medicines to targeted cells and tissues.

3 investors

ResistanceBio develops treatments to address drug resistance in cancer patients.

3 investors

AtlasDiscovery develops foundation models of patient drug response trained on pre-clinical and clinical data to improve drug trial design and success rates. The company serves pharmaceutical and biotech firms by predicting human drug responses and enabling drug rescue and development in the biotech industry.

2 investors

14.ai builds software that automates the core operations of e-commerce brands, handling customer acquisition, order fulfillment, and support with minimal human intervention, and uses the platform to operate its own direct-to-consumer business.

2 investors

Halmos Labs provides automated biotech research and development, running experiments and simulations that address questions from wetlab experiment design through cancer vaccine manufacturing. It serves biotech and pharmaceutical research teams.

2 investors

Keylika develops a platform synthesis technology for mixed ligand metal complexes to generate organometallic drugs for treating therapeutic conditions including hematology, pain, inflammation, metabolic disorders, infectious diseases, and oncology. The company combines drug development with drug delivery technologies, customizing molecular structure and formulation to optimize clinical outcomes for women, children, elderly, and patients with specific diseases.

2 investors

Origin generates spatial molecular maps from patient tumor samples to enable cancer biology research in native tissue context. The platform combines spatial transcriptomics, imaging, and functional perturbation assays on fresh and archived tumors, paired with AI models for drug response prediction and target discovery.

2 investors

Play Health builds a clinical decision-support platform for healthcare providers to deliver personalized menopause and women's health care. The platform serves primary care physicians and other providers treating women navigating perimenopause and menopause.

2 investors

PipeBio provides a bioinformatics platform for drug discovery that enables scientists and bioinformaticians to analyze genomic and assay data. The platform combines sequence data management, machine learning tools, and visualization capabilities to accelerate therapeutic development for academia, biotech companies, and pharmaceutical firms.

2 investors

Rosebud Biosciences develops therapies for rare genetic diseases in children by creating organoid models that replicate patient genetic mutations and using drug screening to identify potential cures. The company uses human-derived organoids combined with robotics and machine learning to accelerate drug discovery across cardiac, hepatic, neural, and kidney disease targets.

2 investors

Synkrino Biotherapeutics develops SATIS, an AI-based system for drug discovery. The company operates in the biotechnology sector.

2 investors

Evolvere BioSciences develops antibiotics using computational models and evolutionary data to target pathogenic bacteria while preserving beneficial microbes, designed to resist the development of bacterial resistance.

1 investor

Macromoltek is a computational drug design company that uses a proprietary platform to produce de novo antibody designs, including against difficult targets not accessible through traditional methods. It serves large biopharmaceutical companies and smaller biotechs.

1 investor

Teevox develops teevoxRemote, an app that turns an iPhone or iPod Touch into a remote control for Hulu and Netflix, offering one-touch show selection, synchronized shared viewing with a friend, and play/pause/volume controls.

1 investor